Jamie P. Dwyer

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

Deepak L. Bhatt, Michael Szarek, Bertram Pitt et al. · New England Journal of Medicine · 2020 · 1.1K citations · Full text

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial

Ofri Mosenzon, Stephen D. Wiviott, Avivit Cahn et al. · The Lancet Diabetes & Endocrinology · 2019 · 656 citations · Full text

Metabolic Syndrome, Declare–timi 58, Diabetes Management +10

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

Kazem Rahimi, Zeinab Bidel, Milad Nazarzadeh et al. · The Lancet · 2021 · 299 citations · Full text

Estimating Baseline Kidney Function in Hospitalized Patients with Impaired Kidney Function

Edward D. Siew, T. Alp İkizler, Michael E. Matheny et al. · Clinical Journal of the American Society of Nephrology · 2012 · 280 citations · Full text

Once-Daily Plazomicin for Complicated Urinary Tract Infections

Florian Wagenlehner, Daniel Cloutier, Allison Komirenko et al. · New England Journal of Medicine · 2019 · 205 citations

Urology, Gram-negative Uropathogens, Antibiotics +12